Clinical trials
Phase 2 HIV Infections trials in Puerto Rico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
85 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 4 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 72 |
| Terminated | 7 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 57 |
| Gilead Sciences | 5 |
| ViiV Healthcare | 5 |
| Agouron Pharmaceuticals | 2 |
| Hoffmann-La Roche | 2 |
| AIDS Malignancy Consortium | 1 |
| Abbott | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Bavarian Nordic | 1 |
| Boehringer Ingelheim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 85 |
| Acquired Immunodeficiency Syndrome | 28 |
| AIDS-Related Complex | 17 |
| Hepatitis C | 3 |
| AIDS-Related Opportunistic Infections | 2 |
| Disease Progression | 2 |
| Pneumonia, Pneumocystis | 2 |
| Sexually Transmitted Diseases | 2 |
| Anus Neoplasms | 1 |
| Bacterial Infections | 1 |
Trials
Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.